AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Nimocard Infusion

Prescription Icon
Prescription Required

Marketer

New Medicon Pharma Labs Pvt Ltd

Salt Composition

Nimodipine (10mg)

Overview Nimocard Infusion

Nimodipine infusion is a medication employed to manage and mitigate cerebral injury following a subarachnoid hemorrhage (brain bleed). Classified as a calcium channel blocker, it enhances cerebral perfusion and safeguards cognitive function. Administration is strictly under medical oversight, with dosage tailored to the indication and condition severity. Continue the infusion as directed by your physician. Adhere meticulously to your doctor's instructions. Frequently reported adverse effects include skin rashes, headaches, gastrointestinal upset, hypotension, and bradycardia. Report any persistent, worsening, or bothersome side effects to your doctor immediately. Dizziness may occur; refrain from operating machinery or driving until the medication's effects are known. Prior to commencing treatment, disclose any pre-existing cardiac conditions. Pregnant or lactating individuals require physician consultation before use. Complete disclosure of all concurrent medications, particularly antihypertensives or cardioactive agents, is crucial.

Primary Ingredients of Nimocard Infusion

No information provided. Please provide the text you wish to be rewritten.

Uses of Nimocard Infusion

Bleeding in the subarachnoid space

Major Benefits of Nimocard Infusion:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Nimocard Infusion:

  • Rash
  • Headache
  • Stomach discomfort
  • Nausea
  • Decreased blood pressure
  • Slow heart rate

How to use Nimocard Infusion:

This medication will be administered by your healthcare provider. Self-medication is not advised.

How Nimocard Infusion works:

Cerebral blood vessel constriction is eased by Nimocard Infusion, a calcium channel antagonist, thereby improving blood flow and mitigating the risk of brain injury following intracranial hemorrhage.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Nimocard Infusion and alcohol may lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Nimocard Infusion during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks before prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Nimocard Infusion safely. Available data from human studies indicate minimal risk to the infant.

DrivingDrivingUNSAFE

Administering Nimocard Infusion may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

The use of Nimocard Infusion in patients with kidney impairment appears to present a low risk. Preliminary findings indicate dose modification may be unnecessary, however, physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Nimocard Infusion's use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Nimocard Infusion :

NA

Facts to Know About Nimocard Infusion

LabelValue
Chemical Type Dihydropyridine carboxylic acid derivatives
Developing Habits No.
Treatment Category Heart
Actions Dihydropyridine Calcium Channel Blockers

FAQs on Nimocard Infusion

Nimocard Infusion, a calcium channel blocker, helps protect brain function after a subarachnoid hemorrhage (brain bleeding from a burst blood vessel).
Nimocard Infusion improves brain blood flow by relaxing and widening blood vessels. This reduces brain damage from internal bleeding and prevents the blood vessels from constricting (vasospasm).
Consult your doctor if you have a history of head injuries or brain bleeds. Disclose all other medications you're taking, as interactions are possible. After intravenous Nimocard Infusion, your doctor may switch you to tablets. Inform your doctor of any heart, brain, or liver problems. Do not take Nimocard Infusion if you're allergic to it. It's not approved for use in children under 18. Avoid antacids for two hours before and after taking Nimocard Infusion. Refrain from alcohol consumption while using Nimocard Infusion to minimize dizziness. Avoid driving or activities requiring alertness. Pregnant, breastfeeding, or planning pregnancy? Consult your doctor before using Nimocard Infusion.
Nimocard Infusion is intravenously administered by a healthcare professional via slow drip infusion. Dosage and treatment duration are determined by your physician based on your condition and weight. Following the infusion, treatment may transition to oral Nimocard tablets. Adhere strictly to your doctor's instructions for optimal results.
Nimocard Infusion (IV) and Nimocard Infusion tablets shouldn't be used concurrently. After the infusion ends, your doctor might prescribe the tablet form to continue treatment.
Nimocard Infusion may cause rash, headache, stomach upset, nausea, low blood pressure, or a fast heart rate. These side effects are typically mild, but contact your doctor if you experience any concerns or worsening symptoms.
Nimocard Infusion
428
MRP 495
13% off